As a tumor suppressor gene targeting the Wnt/β-catenin pathway, RASSF10 overexpression inactivates this pathway and may exert anti-metastatic functions by blocking EMT and inhibiting ESCC cell proliferation [140]. The gene discussed is RASSF10; the disease is esophageal squamous cell carcinoma.